
Luke Evnin
QuietNamed in filings at MPM BioVenturesOn the current fund
- Board seats filed
- 13

Named in filings at MPM BioVenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Umoja Biopharma | Biotech & pharma | June 2021 | None on file |
| Werewolf Therapeutics | Biotech & pharma | August 2019 | None on file |
| Frontier Medicines | Biotech & pharma | April 2019 | None on file |
| Twentyeight-Seven | Biotech & pharma | August 2018 | None on file |
| Harpoon Therapeutics | Biotech & pharma | May 2017 | New Leaf |
| Maverick Therapeutics | Biotech & pharma | January 2017 | None on file |
| Trieza Therapeutics | Biotech & pharma | November 2016 | None on file |
| DigiTx Partners | Not yet classified | July 2016 | None on file |
| Blade Therapeutics | Biotech & pharma | June 2016 | None on file |
| Oncorus | Biotech & pharma | March 2016 | None on file |
| Vesuvius Pharmaceuticals | Not yet classified | December 2014 | None on file |
| Potenza Therapeutics | Biotech & pharma | December 2014 | None on file |
| Amphivena Therapeutics | Biotech & pharma | July 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Luke Evnin on the board, based on 11 filed seats with a verified or cited source.
2 more filed seats not yet classified, left out of the shares above.